Novartis has announced a collaboration with NHS England, the National Institute for Health Research and Oxford University.
The ABPI has welcomed the news that the Conservative Party have won a majority and looks forward to working with the new Government.
The Northern Ireland Department of Health has announced that Northern Ireland (NI) patients will have the same access to new cancer medicines as patients in England.
The Government has announced further details for how they will support pharmaceutical companies’ investments in the development of drugs that will treat AMR infections.
A new survey by the Association of the British Pharmaceutical Industry (ABPI) into links between industry and academia shows a significant rise in the number of higher level apprenticeships across the pharmaceutical industry over the past four years.
The NHS Confederation and the ABPI have today published a new report to help the NHS and life sciences industry work more closely together.
King’s College London, Wellcome and pharmaceutical company MSD announced a collaboration and licencing deal today that could lead to a new class of pain medications.
In response to concerns about the impact a US trade deal would have on medicine pricing, the ABPI continues to emphasise that in the UK, we have very strict rules which control medicine spend.
New figures published today by the ABPI show that the pharmaceutical industry continues to invest significantly in UK research and development, working with healthcare professionals and organisations to improve care for NHS patients.